One of the most standard ways to measure the country’s hospital crisis is to count closures, but one hospital finance expert thinks that isn’t necessarily the right number to watch.

Healthcare isn’t struggling to adopt AI. In fact, the industry has moved quickly from early experimentation to widespread investment in tools designed to improve clinical decision-making, reduce administrative burden, and

The FDA has expanded the approval of a targeted Gilead Sciences therapy as a new first-line treatment for triple-negative breast cancer, tightening competition with a rival drug from the same

Michigan-based insurer Priority Health has teamed up with Garner Health, a digital platform that steers patients to high-performing doctors to lower costs, the companies announced on Wednesday. Priority Health serves

The stats might shock some CTOs and compliance officers. According to the American Medical Association’s most recent Physician AI Sentiment Report, more than 80% of physicians now report using AI

After a few lackluster years, biotech IPOs have rebounded in 2026. A new record for the most cash raised by a biotech in an IPO was set in April only

Ladder Health, a virtual-first pediatric developmental care startup, announced on Tuesday that it secured $7 million in seed funding to expand into new markets. Boston-based Ladder Health supports children aged

Artificial intelligence (AI) is being rapidly adopted throughout the healthcare industry as organizations make more substantial investments in their AI infrastructure, the number of tech-forward pilot programs continues to grow,

AbbVie is boosting its already strong presence in immunology with the acquisition of Apogee Therapeutics, a clinical-stage biotech whose most advanced drug candidate could bring advantages over several currently available

Abarca Health and LucyRx announced last week that they are combining to build an independent pharmacy benefit manager serving commercial and government clients. Together, they’ll support more than 9 million